Resideo jumps as Morgan Stanley upgrades to Overweight, raises target to $35
Resideo Technologies (REZI) shares are higher after Morgan Stanley upgraded the stock to Overweight from Equalweight and lifted its price target to $35 from $24. The move extends momentum after recent focus on earnings power and execution into 2026.
1. What’s moving the stock
Resideo Technologies (REZI) is trading higher today after Morgan Stanley upgraded the shares to Overweight from Equalweight and raised its price target to $35 from $24, pointing to improved earnings potential and a more constructive setup for the stock. (seekingalpha.com)
2. Why the upgrade matters
A major rating change from a large brokerage can quickly reset near-term investor positioning, especially when paired with a large price-target increase. The upgrade reframes Resideo as an improving execution story rather than a wait-and-see name, helping drive incremental buying interest as the market digests the new bull-case assumptions. (seekingalpha.com)
3. Context investors are watching next
Beyond the upgrade, investors continue to focus on Resideo’s 2026 operating trajectory and follow-through on strategic initiatives that have been central to the company’s recent narrative. The next major tests are upcoming quarterly results and any incremental updates on the company’s longer-term margin and earnings cadence. (s206.q4cdn.com)